- CA$121.54bn
- CA$617.06bn
- $86.01bn
- 62
- 32
- 92
- 66
Annual income statement for Brookfield, fiscal year end - December 31st, USD millions except per share, conversion factor applied.
2020 December 31st | 2021 December 31st | 2022 December 31st | 2023 December 31st | 2024 December 31st | |
|---|---|---|---|---|---|
| Period Length: | 12 M | 12 M | 12 M | 12 M | 12 M |
| Source: | ARS | ARS | ARS | ARS | ARS |
| Standards: | IFRS | IFRS | IFRS | IFRS | IFRS |
| Status: | Final | Final | Final | Final | Final |
| Revenue | |||||
| Total Revenue | 62,752 | 75,731 | 92,769 | 95,924 | 86,006 |
| Cost of Revenue | |||||
| Gross Profit | 27,602 | 31,582 | 38,725 | 43,700 | 45,882 |
| Selling / General / Administrative Expenses | |||||
| Depreciation and Amortization | |||||
| Other Operating Expenses | |||||
| Total Operating Expenses | 61,208 | 61,019 | 86,105 | 89,808 | 83,171 |
| Operating Profit | 1,544 | 14,712 | 6,664 | 6,116 | 2,835 |
| Net Income Before Taxes | 1,544 | 14,712 | 6,664 | 6,116 | 2,835 |
| Provision for Income Taxes | |||||
| Net Income After Taxes | 707 | 12,388 | 5,195 | 5,105 | 1,853 |
| Minority Interest | |||||
| Net Income Before Extraordinary Items | |||||
| Net Income | -134 | 3,966 | 2,056 | 1,130 | 641 |
| Adjustments to Net Income | |||||
| Income Available to Common Shareholders Excluding Extraordinary Items | |||||
| Income Available to Common Shareholders Including Extraordinary Items | |||||
| Dilution Adjustment | |||||
| Diluted Net Income | -275 | 3,818 | 1,911 | 969 | 485 |
| Diluted Weighted Average Shares | |||||
| Basic EPS Including Extraordinary Items | |||||
| Diluted EPS Including Extraordinary Items | |||||
| Diluted EPS Excluding Extraordinary Items | |||||
| Normalised Income Before Taxes | |||||
| Normalised Income After Taxes | |||||
| Normalised Income Available to Common Shareholders | |||||
| Diluted Normalised EPS | -0.182 | 2.63 | 1.19 | 0.61 | 0.306 |
| Dividends per Share |